Shin Yonehara
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Shin Yonehara has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Kazuhiro Sakamaki
Graduate School of Biostudies Kyoto University Kyoto Japan
4 shared publications K Watanabe
Graduate School of Biostudies and Institute for Virus Research, Kyoto University, Kyoto, Japan
2 shared publicationsNobuyuki Yajima
Graduate School of Biostudies and Institute for Virus Research, Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan
2 shared publicationsC Mori
Graduate School of Biostudies and Institute for Virus Research, Kyoto University, Shogoin-Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
1 shared publicationK Iijima
1 shared publicationK Okamoto
Graduate School of Biostudies and Institute for Virus Research, Kyoto University, Kyoto, Japan
1 shared publication
Latest Publications
- 12 November 2004
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 12 (1) , 10-18
Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP
Fas-mediated apoptosis plays an important role in elimination of tumor cells in vivo, but some tumor-derived cells are resistant to this mechanism. Here, we show that treatment with the histone deacetylase (HDAC) inhibitor FR901228 renders Fas-resistant osteosarcoma cell lines sensitive to Fas-mediated apoptosis by downregulating expression of cellular FLIP (cellular FLICE-inhibitory protein), an inhibitor of Fas-mediated activation of caspase-8. Moreover, sensitization to Fas-mediated apoptosis was also induced in Fas-resistant osteosarcoma cells by suppressing FLIP expression using FLIP-specific RNA interference. HDAC inhibitors including FR901228 were shown to induce downregulation of cellular FLIP through inhibiting generation of FLIP mRNA, rather than stimulating degradation at either protein or mRNA level, and the inhibition was independent of de novo protein synthesis. These results clearly indicate that some tumor cells exhibit a phenotype resistant to death receptor-mediated apoptosis by expressing cellular FLIP, and that HDAC inhibitors sensitize such resistant tumor cells by directly downregulating cellular FLIP mRNA.
- 12 November 2004
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 12 (1) , 10-18
Sensitization of osteosarcoma cells to death receptor-mediated apoptosis by HDAC inhibitors through downregulation of cellular FLIP
Fas-mediated apoptosis plays an important role in elimination of tumor cells in vivo, but some tumor-derived cells are resistant to this mechanism. Here, we show that treatment with the histone deacetylase (HDAC) inhibitor FR901228 renders Fas-resistant osteosarcoma cell lines sensitive to Fas-mediated apoptosis by downregulating expression of cellular FLIP (cellular FLICE-inhibitory protein), an inhibitor of Fas-mediated activation of caspase-8. Moreover, sensitization to Fas-mediated apoptosis was also induced in Fas-resistant osteosarcoma cells by suppressing FLIP expression using FLIP-specific RNA interference. HDAC inhibitors including FR901228 were shown to induce downregulation of cellular FLIP through inhibiting generation of FLIP mRNA, rather than stimulating degradation at either protein or mRNA level, and the inhibition was independent of de novo protein synthesis. These results clearly indicate that some tumor cells exhibit a phenotype resistant to death receptor-mediated apoptosis by expressing cellular FLIP, and that HDAC inhibitors sensitize such resistant tumor cells by directly downregulating cellular FLIP mRNA.
- Open Access
- 1 June 2004
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (26) , 26807-26810
Chemokines Generally Exhibit Scavenger Receptor Activity through Their Receptor-binding Domain
- 1 June 2004
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 279 (26) , 26807-26810
Open AccessChemokines Generally Exhibit Scavenger Receptor Activity through Their Receptor-binding Domain
- Open Access
- 24 May 2004
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 16 (7) , 1027-1035
Age-related thymic involution is mediated by Fas on thymic epithelial cells
Age‐related thymic involution, which is linked to senescence of the immune system, was found to be mediated by the death receptor Fas. The thymus of aged Fas–/– mice exhibited an intact structure and the normal differentiation of thymocytes. Both thymocytes and thymic epithelial cells (TECs) were sensitive to Fas‐mediated apoptosis, and in vivo stimulation of wild‐type thymocytes with anti‐CD3 mAb was shown to induce apoptosis in TECs in a Fas‐dependent manner. In addition, thymopoiesis continued uninterrupted in aged Fas–/– mice that had been lethally irradiated and reconstituted with bone marrow cells derived from wild‐type mice, while age‐related thymic involution was observed in irradiated wild‐type mice reconstituted with bone marrow cells from either Fas–/– or wild‐type mice. The results indicate that Fas on TECs plays a key role in age‐related thymic involution.
- 24 May 2004
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 16 (7) , 1027-1035
Open AccessAge-related thymic involution is mediated by Fas on thymic epithelial cells
Age‐related thymic involution, which is linked to senescence of the immune system, was found to be mediated by the death receptor Fas. The thymus of aged Fas–/– mice exhibited an intact structure and the normal differentiation of thymocytes. Both thymocytes and thymic epithelial cells (TECs) were sensitive to Fas‐mediated apoptosis, and in vivo stimulation of wild‐type thymocytes with anti‐CD3 mAb was shown to induce apoptosis in TECs in a Fas‐dependent manner. In addition, thymopoiesis continued uninterrupted in aged Fas–/– mice that had been lethally irradiated and reconstituted with bone marrow cells derived from wild‐type mice, while age‐related thymic involution was observed in irradiated wild‐type mice reconstituted with bone marrow cells from either Fas–/– or wild‐type mice. The results indicate that Fas on TECs plays a key role in age‐related thymic involution.
- 22 May 2003
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 10 (6) , 676-686
Involvement of death receptor Fas in germ cell degeneration in gonads of Kit-deficient Wv/Wv mutant mice
Kit and its ligand stem cell factor (SCF) play a fundamental role in hematopoiesis, melanogenesis and gametogenesis. Homozygous Wv mutant mice with a mutation in kit show abnormalities in these cell lineages. Fas is a member of the death receptor family inducing apoptosis. In this study, we generated double-mutant mice (Wv/Wv:Fas-/-) and analyzed histologically their reproductive organs. In testes and ovaries of the double-mutant mice, testicular germ cells and oocytes were detected, respectively, whereas the same-aged Wv/Wv mice contained neither cells. In addition, inhibition of Kit signals by administration of anti-Kit mAb, which induces degeneration of testicular germ cells in vivo in wild-type mice, did not cause degeneration in Fas-deficient mice. In testicular germ cells of Wv/Wv mutant mice, an increase of Fas expression was observed in spermatogonia. Further, in vitro treatment with SCF was shown to downregulate Fas on fibroblasts expressing exogenous Kit through activation of PI3-kinase/Akt. All the results clearly indicate that Fas-mediated apoptosis is involved in germ cell degeneration accompanied by defects in Kit-mediated signals, and Kit signaling negatively regulates Fas-mediated apoptosis in vivo.
- 22 May 2003
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 10 (6) , 676-686
Involvement of death receptor Fas in germ cell degeneration in gonads of Kit-deficient Wv/Wv mutant mice
Kit and its ligand stem cell factor (SCF) play a fundamental role in hematopoiesis, melanogenesis and gametogenesis. Homozygous Wv mutant mice with a mutation in kit show abnormalities in these cell lineages. Fas is a member of the death receptor family inducing apoptosis. In this study, we generated double-mutant mice (Wv/Wv:Fas-/-) and analyzed histologically their reproductive organs. In testes and ovaries of the double-mutant mice, testicular germ cells and oocytes were detected, respectively, whereas the same-aged Wv/Wv mice contained neither cells. In addition, inhibition of Kit signals by administration of anti-Kit mAb, which induces degeneration of testicular germ cells in vivo in wild-type mice, did not cause degeneration in Fas-deficient mice. In testicular germ cells of Wv/Wv mutant mice, an increase of Fas expression was observed in spermatogonia. Further, in vitro treatment with SCF was shown to downregulate Fas on fibroblasts expressing exogenous Kit through activation of PI3-kinase/Akt. All the results clearly indicate that Fas-mediated apoptosis is involved in germ cell degeneration accompanied by defects in Kit-mediated signals, and Kit signaling negatively regulates Fas-mediated apoptosis in vivo.
- Open Access
- 1 January 2003
- Published by Japan Society for Cell Biology in Cell Structure and Function
- Vol. 28 (1) , 1-2
To Reviews on Physiological and Pathological Roles of Cell Death
- 1 January 2003
- Published by Japan Society for Cell Biology in Cell Structure and Function
- Vol. 28 (1) , 1-2
Open AccessTo Reviews on Physiological and Pathological Roles of Cell Death
- 1 December 2002
- Vol. 47, 2268-73
[Molecular regulatory mechanism of Fas-mediated apoptosis].
- 1 August 2002
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 13 (4-5) , 393-402
Death receptor Fas and autoimmune disease: from the original generation to therapeutic application of agonistic anti-Fas monoclonal antibody
- 1 August 2002
- Published by Elsevier in Cytokine & Growth Factor Reviews
- Vol. 13 (4-5) , 393-402
Death receptor Fas and autoimmune disease: from the original generation to therapeutic application of agonistic anti-Fas monoclonal antibody
- 1 March 2001
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 8 (3) , 298-307
Apoptosis-inducing protein, AIP, from parasite-infected fish induces apoptosis in mammalian cells by two different molecular mechanisms
Cell death and differentiation is a monthly research journal focused on the exciting field of programmed cell death and apoptosis. It provides a single accessible source of information for both scientists and clinicians, keeping them up-to-date with advances in the field. It encompasses programmed cell death, cell death induced by toxic agents, differentiation and the interrelation of these with cell proliferation.
- 1 March 2001
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 8 (3) , 298-307
Apoptosis-inducing protein, AIP, from parasite-infected fish induces apoptosis in mammalian cells by two different molecular mechanisms
Cell death and differentiation is a monthly research journal focused on the exciting field of programmed cell death and apoptosis. It provides a single accessible source of information for both scientists and clinicians, keeping them up-to-date with advances in the field. It encompasses programmed cell death, cell death induced by toxic agents, differentiation and the interrelation of these with cell proliferation.
- Open Access
- 1 April 2000
- Published by Wiley in Microbiology and Immunology
- Vol. 44 (4) , 289-297
Reduction of Thymocyte Numbers in Transgenic Mice Expressing Viral FLICE‐Inhibitory Protein in a Fas‐Independent Manner
A viral FLIP (FLICE/caspase‐8‐Inhibitory Protein), equine herpesvirus type 2 E8 protein, has been shown to inhibit Death receptor‐induced apoptosis by suppressing the activation of FLICE/caspase‐8. We generated transgenic mice specifically expressing E8 in thymocytes under the control of lck‐proximal promoter. Although E8‐expressing thymocytes were resistant to Fas‐mediated apoptosis, the total number of thymocytes in 4‐8‐week‐old E8 transgenic mice was more than 3‐fold less than that in control littermates. This reduction was also observed in E8 transgenic mice with a Fas–/– background suggesting the reduction to be independent of Fas. The thymocytes of the transgenic mice, however, could similarly respond to CD3‐mediated stimulation, indicating that the reduction of thymocyte numbers might be independent of T cell receptor complex‐mediated stimulation. Thus, the Death receptor‐mediated signaling pathway is too complex to be regarded as only an executor for apoptosis.
- 1 April 2000
- Published by Wiley in Microbiology and Immunology
- Vol. 44 (4) , 289-297
Open AccessReduction of Thymocyte Numbers in Transgenic Mice Expressing Viral FLICE‐Inhibitory Protein in a Fas‐Independent Manner
A viral FLIP (FLICE/caspase‐8‐Inhibitory Protein), equine herpesvirus type 2 E8 protein, has been shown to inhibit Death receptor‐induced apoptosis by suppressing the activation of FLICE/caspase‐8. We generated transgenic mice specifically expressing E8 in thymocytes under the control of lck‐proximal promoter. Although E8‐expressing thymocytes were resistant to Fas‐mediated apoptosis, the total number of thymocytes in 4‐8‐week‐old E8 transgenic mice was more than 3‐fold less than that in control littermates. This reduction was also observed in E8 transgenic mice with a Fas–/– background suggesting the reduction to be independent of Fas. The thymocytes of the transgenic mice, however, could similarly respond to CD3‐mediated stimulation, indicating that the reduction of thymocyte numbers might be independent of T cell receptor complex‐mediated stimulation. Thus, the Death receptor‐mediated signaling pathway is too complex to be regarded as only an executor for apoptosis.
- 1 January 1999
- Published by Taylor & Francis in International Reviews of Immunology
- Vol. 18 (4) , 329-345
Effects of Anti-Fas Antibodies on Lymphocytes and Other Organs: Preparation of Original and New Monoclonal Antibodies and Amelioration of Systemic Autoimmune Disease
Fifteen and ten years have passed since original anti-human Fas mAb CH-11 with associated apoptosis-inducing activity was prepared in 1984 and reported in 1989, respectively. Fas antigen (FS-7 cell-associated cell surface antigen) has been shown to be a cell surface receptor molecule (Fas) which can introduce apoptosis-inducing signals into Fas-bearing cells. Studies on lpr (lymphoproliferation) and gld (generalized lymphoproliferative disease) mice, which are loss-of-function mutant mice of Fas and Fas ligand (FasL), respectively, show that these mutations are responsible for the early onset of systemic autoimmune disease in MRL mice, suggesting that autoreactive immunocytes are eliminated by the function of Fas/FasL system (“physiological function” of Fas). Fas/FasL system, however, plays an important role in not only prevention but also aggravation of autoimmune disease. Fas/FasL was shown to be involved in the mechanisms responsible for tissue disruption in autoimmune diseases (“pathological function” of Fas). Studies on the in vivo administration of anti-mouse Fas mAbs, Jo2 and RK-8, emphasized pathological and physiological functions of Fas, respectively: Jo2 induces fulminant hepatitis and RK-8 ameliorates systemic autoimmune disease without the induction of fulminant hepatitis. The different in vivo effects of Jo2 and RK-8 coincide well with different target cell specificity of these mAbs in vitro. Similarly, I observed different target cell specificity on anti-human Fas mAbs. In this review, I propose new strategy of therapeutic use of anti-Fas mAb as specific suppressor for activated immune system on autoimmune disease and other diseases.
- 1 January 1999
- Published by Taylor & Francis in International Reviews of Immunology
- Vol. 18 (4) , 329-345
Effects of Anti-Fas Antibodies on Lymphocytes and Other Organs: Preparation of Original and New Monoclonal Antibodies and Amelioration of Systemic Autoimmune Disease
Fifteen and ten years have passed since original anti-human Fas mAb CH-11 with associated apoptosis-inducing activity was prepared in 1984 and reported in 1989, respectively. Fas antigen (FS-7 cell-associated cell surface antigen) has been shown to be a cell surface receptor molecule (Fas) which can introduce apoptosis-inducing signals into Fas-bearing cells. Studies on lpr (lymphoproliferation) and gld (generalized lymphoproliferative disease) mice, which are loss-of-function mutant mice of Fas and Fas ligand (FasL), respectively, show that these mutations are responsible for the early onset of systemic autoimmune disease in MRL mice, suggesting that autoreactive immunocytes are eliminated by the function of Fas/FasL system (“physiological function” of Fas). Fas/FasL system, however, plays an important role in not only prevention but also aggravation of autoimmune disease. Fas/FasL was shown to be involved in the mechanisms responsible for tissue disruption in autoimmune diseases (“pathological function” of Fas). Studies on the in vivo administration of anti-mouse Fas mAbs, Jo2 and RK-8, emphasized pathological and physiological functions of Fas, respectively: Jo2 induces fulminant hepatitis and RK-8 ameliorates systemic autoimmune disease without the induction of fulminant hepatitis. The different in vivo effects of Jo2 and RK-8 coincide well with different target cell specificity of these mAbs in vitro. Similarly, I observed different target cell specificity on anti-human Fas mAbs. In this review, I propose new strategy of therapeutic use of anti-Fas mAb as specific suppressor for activated immune system on autoimmune disease and other diseases.